Hospital Universitario Basurto

Bilbao 48013

0 studies enrolling now · 2 studies all time

What they study most

Amyotrophic Lateral Sclerosis, Complete Response, Epithelial Ovarian Cancer, FIGO Stage III-IV, Fallopian Tube Cancer, Newly Diagnosed, Partial Response, Primary Peritoneal

Studies at this site

• A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) — Stopped early